Literature DB >> 20803336

Differences in in vitro photodynamic sensitivity among head and neck cancers.

V Boonkitticharoen1, B Kulapaditharom, S Punnachaiya, P Kraiphibul.   

Abstract

This study was conducted to address the question of how cancers of different histologies of the head and neck region responded to photodynamic therapy (PDT). Five human cancer cell lines were investigated: two squamous cell carcinoma lines (pharynx and tongue), mucoepidermoid carcinoma (submaxillary gland), rhabdomyosarcoma (embryonic) and adenocarcinoma (colon). The cell lines were treated with haematoporphyrin derivative (HpD) at doses of 0.78-25Mug ml(-1), with excitation of the absorbed drug by a 'black light' source (340-380 nm). An MTT assay demonstrated different PDT responses among the various cell types. On the basis of LD(50), the sensitivity of the different cell lines was ranked as follows: adenocarcinoma> squamous cell carcinoma> rhabdomyosarcoma> mucoepidermoid carcinoma. The magnitude of the LD(50) was suggested by a drug uptake study to be governed in part by cellular levels of sensitizer and in part by intrinsic cell sensitivity. This study provided information that may help to identify the histological types of head and neck cancers that would respond favourably to PDT.

Entities:  

Year:  1997        PMID: 20803336     DOI: 10.1007/BF02765109

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  15 in total

1.  Sensitivity of different human lung cancer histologies to photodynamic therapy.

Authors:  R R Perry; W Matthews; J B Mitchell; A Russo; S Evans; H I Pass
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

2.  Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro.

Authors:  A P McHale; L McHale
Journal:  Cancer Lett       Date:  1988-08-30       Impact factor: 8.679

3.  Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial.

Authors:  L I Grossweiner; J H Hill; R V Lobraico
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

Review 4.  Clinical and preclinical photodynamic therapy.

Authors:  A M Fisher; A L Murphree; C J Gomer
Journal:  Lasers Surg Med       Date:  1995       Impact factor: 4.025

5.  An improved MTT assay.

Authors:  D Sladowski; S J Steer; R H Clothier; M Balls
Journal:  J Immunol Methods       Date:  1993-01-04       Impact factor: 2.303

6.  Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck.

Authors:  B L Wenig; D M Kurtzman; L I Grossweiner; M F Mafee; D M Harris; R V Lobraico; R A Prycz; E L Appelbaum
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-11

7.  Evidence for deficiency of low density lipoprotein receptor on human colonic carcinoma cell lines.

Authors:  M Fabricant; S A Broitman
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

Review 8.  Photodynamic therapy in oncology: mechanisms and clinical use.

Authors:  H I Pass
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

9.  Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity.

Authors:  W E Grant; C Hopper; P M Speight; A J Macrobert; S G Bown
Journal:  J Laryngol Otol       Date:  1993-12       Impact factor: 1.469

10.  Size-dependent resistance of human tumour spheroids to photodynamic treatment.

Authors:  C M West
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.